Risorse esterne
Opinione della community
Prezzo Variazione Volume
3 0 €
P/E Obiettivo ad 1anno
0 6.77 €

Compra - Vendi

Tutte le tue transazioni per questo titolo

Devi effettuare l'accesso


Altri utenti che hanno investito

Transations in last week
Buy: 12
Sell : 3

Giovanni Clarizia Leonardo Flori Simone Bonzanini



Should You Sell Cardiome Pharma Corporation Based On Current Broker Views? - NewsDen

... capitalization is 95.63M, it has a 52-week low of 2.35 and a 52-week high of 6.36. The share price of the company (CRME) was up +0.00%, with a high of 3.02 during the day and the volume of Cardiome Pharma Corporation shares traded was 66040. Leggi

Research Reports Initiated on Healthcare Stocks Theratechnologies, Concordia International, Aurinia Pharmaceuticals ... - Yahoo Finance

LONDON, UK / ACCESSWIRE / February 15, 2017 / Active Wall St. announces the list of stocks for today's research reports. Pre-market the Active Wall St. team provides the technical coverage impacting selected stocks trading on the Toronto Exchange and ...altro » Leggi

Cardiome Pharma Corporation (NASDAQ:CRME) Average Rating At 3.75 - Markets Daily

It entails about the likelihood of stock movement 1% plus or minus, in a certain trading session. Cardiome Pharma Corporation was given a 0 for the session as on 2017-02-14. The mechanism of computationally listing and conveying pinions in news ...altro » Leggi

Earnings in focus: Cardiome Pharma Corp. (NASDAQ:CRME)'s track record - Post Analyst

Cardiome Pharma Corp. (NASDAQ:CRME) is trading down on a volume of 0.03 million, or 0.5 times its standard daily volume. Shares have dropped -2.07% to $2.84. It has gained $3.52 (-55.35%) since hitting a 52-week high price of $6.36. The stock has ... Leggi

Average Rating Of Cardiome Pharma Corporation (NASDAQ:CRME) At 3.75 - Markets Daily

It construes how likely equity can hit a minimum 1% movement in trading session. Cardiome Pharma Corporation was given a 0 for the session as on 2017-01-24. Sentiment reading can be taken to find the sentiment on equity. It reports the crowd's ...altro » Leggi

Reviewing Individual Broker Targets Of Cardiome Pharma Corporation (CRME) - NewsDen

(Cardiome) is a specialty pharmaceutical company. The Company is engaged in the development and commercialization of cardiovascular therapies for heart disease. The Company's segments are Europe and Rest of World. Cardiome has two marketed, ... Leggi

Average Price Target Of 9.98 Issued For Cardiome Pharma Corporation (CRME) - Fiscal Standard

Currently 8 analysts have outstanding research reports on Cardiome Pharma Corporation (CRME), according to the reports 2 analysts rate the stock “Buy”, 5 “Outperform”, 0 “Underperform”, 0 “Sell”, while 1 “Hold”. The most recently updated ratings and ... Leggi

Cardiome Pharma Corporation (CRME) Reviewed By Analysts - The De Soto Edge

Stock market analysts watching Cardiome Pharma Corporation (CRME) have recently changed their ratings on the stock. The latest reports which are outstanding on Wednesday 1st of February state 2 analysts have a rating of “strong buy”, 5 analysts “buy”, ...altro » Leggi

Cardiome Pharma Corporation (NASDAQ:CRME) Strong Sell Recommendations At 0 - Investor Newswire

Zacks rating has in place a unique mechanism that gives a consensus rating considering market wide analysts' opinion. It collects the score from different brokerages, the process gives a single score on 1-5 base. Since strong call is known by score of ...altro » Leggi

Aurinia Pharmaceuticals Inc (AUPH) Names Dr. Richard M. Glickman as New CEO - Smarter Analyst

He currently serves as founding Chairman of Essa Pharmaceuticals Inc., Chairman of the Board of Engene Corporation and a Director of Cardiome Pharma. He is also a ... Shares of Aurinia are down over 3% to $3.23 in after-hours trading. AUPH has a 1-year ...altro » Leggi